Orserdu Interactions
There are 290 drugs known to interact with Orserdu (elacestrant), along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 92 are major, 157 are moderate, and 41 are minor.
- View all 290 medications that may interact with Orserdu
- View Orserdu alcohol/food interactions (1)
- View Orserdu disease interactions (1)
Most frequently checked interactions
View interaction reports for Orserdu (elacestrant) and the medicines listed below.
- 12 Hour Nasal Decongestant Spray (oxymetazoline nasal)
- albuterol
- Ambien (zolpidem)
- amlodipine / benazepril
- Anoro Ellipta (umeclidinium / vilanterol)
- aspirin
- atenolol
- atorvastatin
- azelastine nasal
- Benadryl (diphenhydramine)
- biotin
- Breztri Aerosphere (budesonide / formoterol / glycopyrrolate)
- Calcium 600 D (calcium / vitamin d)
- calcium carbonate
- calcium citrate
- Claritin (loratadine)
- Compazine (prochlorperazine)
- famotidine
- Imitrex (sumatriptan)
- MiraLAX (polyethylene glycol 3350)
- multivitamin
- omeprazole
- oxybutynin
- valacyclovir
- Verzenio (abemaciclib)
- Vitamin D3 (cholecalciferol)
- warfarin
- Xarelto (rivaroxaban)
- Xgeva (denosumab)
- Zofran (ondansetron)
Orserdu alcohol/food interactions
There is 1 alcohol/food interaction with Orserdu (elacestrant).
Orserdu disease interactions
There is 1 disease interaction with Orserdu (elacestrant) which include:
Report options
QR code containing a link to this page
More about Orserdu (elacestrant)
- Orserdu consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: estrogen receptor antagonists
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
